Telemetry Investments, L.L.C. Gain Therapeutics, Inc. Put Options Transaction History
Telemetry Investments, L.L.C.
- $63.3 Million
- Q4 2022
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding GANX
# of Institutions
37Shares Held
3.52MCall Options Held
8.4KPut Options Held
8.7K-
David Einhorn Greenlight Capital Inc | New York, Ny588KShares$1.18 Million0.1% of portfolio
-
Dme Capital Management, LP New York, NY566KShares$1.14 Million0.05% of portfolio
-
Jones Financial Companies Lllp428KShares$859,6760.0% of portfolio
-
Geode Capital Management, LLC Boston, MA282KShares$567,2440.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA255KShares$512,5290.0% of portfolio
About Gain Therapeutics, Inc.
- Ticker GANX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,883,400
- Market Cap $23.9M
- Description
- Gain Therapeutics, Inc., a biotechnology company, engages in developing various therapies to treat diseases caused by protein misfolding. It focuses on rare genetic diseases and neurological disorders. The company uses its Site-Directed Enzyme Enhancement Therapy platform to discover allosteric sites on misfolded proteins and identify proprietar...